Net Cash Provided by (Used in) Operating Activities |
-19.3K |
USD |
-105% |
Q2 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
19.3K |
USD |
+105% |
Q2 2024 |
Q1 2025 |
Common Stock, Shares Authorized |
10B |
shares |
0% |
Q3 2024 |
Q2 2025 |
Common Stock, Shares, Issued |
760M |
shares |
0% |
Q3 2024 |
Q2 2025 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2024 |
Q2 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
0 |
USD |
|
Q3 2024 |
Q2 2025 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
0 |
USD |
|
Q2 2024 |
Q1 2025 |
Deferred Tax Assets, Valuation Allowance |
169K |
USD |
+8.6% |
Q1 2024 |
FY 2024 |
Deferred Tax Assets, Gross |
169K |
USD |
+8.6% |
Q1 2024 |
FY 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
805K |
USD |
+8.6% |
Q1 2024 |
FY 2024 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2024 |
Q2 2025 |
Preferred Stock, Shares Authorized |
10M |
shares |
0% |
Q3 2024 |
Q2 2025 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2024 |
Q2 2025 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q1 2024 |
FY 2024 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2024 |
Q2 2025 |